Merger • Life Science

RoslinCT Acquires Lykan Bioscience

On June 5, 2023, RoslinCT acquired life science company Lykan Bioscience from WindRose Health Investors

Acquisition Context
  • This is RoslinCT’s 1st transaction in the Life Science sector.
  • This is RoslinCT’s 1st transaction in the United States.
  • This is RoslinCT’s 1st transaction in Massachusetts.

Explore All 192 Merger Life Science Deals - Search the Database Free


M&A Deal Summary

Date June 5, 2023
Target Lykan Bioscience
Sector Life Science
Buyer(s) RoslinCT
Sellers(s) WindRose Health Investors
Deal Type Merger

Target Company

Lykan Bioscience

Hopkinton, Massachusetts, United States
Lykan Bioscience is a manufacturing services organization, focused on providing outsourced end-to-end production and logistics solutions for pharmaceutical and biotech companies focused on cell and gene therapies. Lykan Bioscience is based in Hopkinton, Massachusetts.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

RoslinCT

Edinburgh, United Kingdom

Category Company
Sector Life Science
DESCRIPTION

RoslinCT is a global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. RoslinCT is based in Edinburgh, United Kingdom.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Merger 1 of 1
State: Massachusetts 1 of 1
Country: United States 1 of 1
Year: 2023 1 of 1

Seller Profile 1

SELLER

WindRose Health Investors

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 2.5B USD
Size Large
Type Sector Focused
DESCRIPTION

MTS Health Investors LLC is a specialist private investment firm focused on opportunities in the services sectors of the healthcare industry. Specific areas of interest include managed care/health insurance, healthcare providers, distributors of medical/products and providers of outsourced services. MTS also invests in low-technology medical product manufacturers. MTS makes equity investments in US based companies valued between $25 and $300 million. Prospective transaction types include buyouts, divestitures, recapitalizations, take-privates, acquisition financings, and growth financings. MTS Health Investors was formed in 2000 and is based in New York City.


Deal Context for Seller #
Overall 24 of 28
Sector: Life Science 3 of 3
Type: Merger 2 of 2
State: Massachusetts 2 of 2
Country: United States 24 of 28
Year: 2023 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-16 ThirdWaveRX

Las Vegas, Nevada, United States

ThirdWaveRX is a pharmaceutical rebate manager offering market-differentiated services to LTC facilities, hospitals, oncology practices, and other specialty provider groups. Its TWRx platform leverages advanced technology, analytics, and nationwide industry contracts to analyze and reduce clients’ net drug costs. ThirdWaveRX is based in Las Vegas, Nevada.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-27 MDSave

Brentwood, Tennessee, United States

MDSave provides a single online location for consumers to research, compare and purchase medical services with total cost transparency. MDSave was formed in 2011 and is based in Brentwood, Tennessee.

Sell -